Clues to be found in more personalized treatment for multiple myeloma can be found in the genetics of myeloma in each individual patient. Dr. Gareth Morgan and the UAMS Myeloma Institute in collaboration with the Dana Farber Cancer Institute and other institutions are working to collect genomic data from myeloma patients with the goal of segmenting patients into groups that could lead to more personalized therapy. Learn more about why this matters to you as a myeloma patient and how you can weigh in to help researchers come to conclusions faster. Listen Now
The Myeloma Genome Project with Dr. Gareth Morgan, UAMS Myeloma Institute
- Multiple Myeloma Research Foundation (MMRF) Announces $4 Million Investment from the Perelman Family Foundation to Launch MMRF Prevention Project
- Climb and Punishment–Uphill, Roadkill, and More.
- Fuel my Ride–Ice Cream Please!
- Multiple myeloma treatment advances: What health execs should know
- My First Big Dam Post